ALBANY, New York, May 1, 2015 /PRNewswire/ -- Albany Molecular
Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief
Executive Officer, will present at the Bank of America Merrill
Lynch 2015 Health Care Conference on Wednesday, May 13, 2015 at 4:20 p.m. ET.
A live audio webcast of the presentation can be accessed at
AMRI's Investor Relations web site at
http://ir.amriglobal.com/events.cfm?CalendarID=2
The webcast will be archived for 90 days following the live
presentation.
About AMRI
Albany Molecular Research Inc. (AMRI) is a global contract
research and manufacturing organization that has been working with
the Life Sciences industry to improve patient outcomes and the
quality of life for more than two decades. With locations in
North America, Europe and Asia, our key business segments include
Discovery and Development Services (DDS), Active Pharmaceutical
Ingredients (API) and Drug Product Manufacturing. Our DDS segment
provides comprehensive services from hit identification to IND,
including expertise with diverse chemistry, library design and
synthesis, in vitro biology and pharmacology, drug
metabolism and pharmacokinetics, as well as natural products. API
Manufacturing supports the chemical development and cGMP
manufacture of complex API, including potent, controlled
substances, biologics, peptides, steroids and cytotoxic compounds.
Drug Product Manufacturing supports drug product development
through commercial scale production of complex liquid-filled and
lyophilized parenteral formulations. For more information about
AMRI, please visit our website at www.amriglobal.com or follow us
on Twitter (@amriglobal).